Gregory M. Sullivan is Chief Medical Officer at Tonix Pharmaceuticals Holding Corp. (TNXP). They have made 6 open-market trades across 1 company since 2015, most recently 2025-02-05.
CIK 0001610106
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $202K since 2015, never a sale. Across 6 scored buys the stock is down 21.6% at ninety days, and 24.4 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| TNXP | 99,223 | $601K |
Shares reported on the most recent Form 4, priced at the 2022-02-11 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 50% | 50% |
| Avg Move | -18.5% | -4.9% | -21.6% |
| Alpha | -15.7% | -4.9% | -24.4% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TNXP | BUY | 2020-08-17 | 2020-08-19 | $1.03 | $21K | -9.7% | -5.8% | -39.8% |
| TNXP | BUY | 2018-06-14 | 2018-06-15 | $3.97 | $40K | +4.1% | -5.2% | -83.2% |
| TNXP | BUY | 2016-06-03 | 2016-06-03 | $2.50 | $50K | -5.7% | -21.8% | -9.6% |
| TNXP | BUY | 2015-09-30 | 2015-09-30 | $5.18 | $26K | -33.2% | +1.1% | +1.1% |
| TNXP | BUY | 2015-09-28 | 2015-09-28 | $5.95 | $28K | -33.2% | +1.1% | +1.1% |
| TNXP | BUY | 2015-06-11 | 2015-06-11 | $8.38 | $38K | -33.2% | +1.1% | +1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.